Close Menu

NEW YORK — The US Food and Drug Administration has granted separate Emergency Use Authorizations for SARS-CoV-2 tests developed by Gencurix and Laihe Biotech.

Gencurix' GenePro SARS-CoV-2 Test is designed to detect the virus' Orf1-ab and RdRP genes in nasopharyngeal swab samples. It runs on Thermo Fisher Scientific's Applied Biosystems QuantStudio Dx RT-PCR instrument or Bio-Rad's CFX96 RT-PCR system, and can be used with 384-well plates, according to the company. Based in Seoul, South Korea, Gencurix develops molecular diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.